AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
Clinical trials for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT trials appear
Sign up with your email to follow new studies for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boosting the immune system after transplant: could 'Killer' cells prevent relapse?
Disease control CompletedThis study tests whether giving patients their own specially grown immune cells (called cytokine-induced killer cells) shortly after a stem cell transplant is safe. The trial enrolls adults with lymphoma who are receiving a transplant of their own stem cells. Researchers will mon…
Matched conditions: AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
Phase: NA • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Shocking therapy may keep cancer patients on their feet
Symptom relief CompletedThis study tested whether neuromuscular electrical stimulation (NMES) can help Veterans with blood cancers maintain physical function and reduce fatigue during stem cell transplant. 46 participants used NMES while in the hospital. The goal was to see if this approach could preven…
Matched conditions: AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC